BIOMAT Database Logo BIOMAT Database Logo

[Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma]. 1992

H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Centre Léon-Bérard, Lyon, France.

Twenty cases of endometrial carcinoma are reported, observed in women who had received long term tamoxifen treatment as adjuvant therapy for breast cancer. Furthermore, a specific study was carried out on an homogeneous group of 790 women with an operable breast cancer, 318 receiving tamoxifen as adjuvant treatment. Five endometrium carcinoma were observed in the group under tamoxifen versus none in the other group. From an analysis of these cases, authors will carry out a case control study to evaluate the relative risk of endometrial carcinoma for patients under tamoxifen. They underline the importance of gynecologic follow up procedures for all women receiving this endocrine therapy.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial

Related Publications

H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
May 1998, Australasian radiology,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Subsequent endometrial carcinoma with adjuvant tamoxifen treatment in Japanese breast cancer patients.
January 2001, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
[Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
January 2003, Voprosy onkologii,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.
April 1990, New York state journal of medicine,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
December 1996, Gynecologic oncology,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
January 1999, European journal of obstetrics, gynecology, and reproductive biology,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen.
September 2013, The journal of obstetrics and gynaecology research,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
March 1996, Gynecologic oncology,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Overprolonged adjuvant tamoxifen therapy in breast cancer.
June 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
H Mignotte, and A J Sasco, and C Lasset, and S Saez, and M Rivoire, and J Y Bobin
Tamoxifen therapy for breast cancer and endometrial cancer risk.
October 1999, Journal of the National Cancer Institute,
Copied contents to your clipboard!